Atlanta, GA, United States of America

Efrain M Ribot

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Efrain M Ribot. Retrieved from https://idiyas.com/inventor/efrain-m-ribot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Efrain M. Ribot: Inventor in Meningococcal Research

Introduction

Efrain M. Ribot is an inventor associated with Atlanta, Georgia, and research on *Neisseria meningitidis* serogroup B. His patent work addresses genetic and molecular tools related to bacterial invasion.

Latest Patents

Ribot is credited with 1 patent: “Invasion Associated Genes from *Neisseria meningitidis* Serogroup B.” The patent describes genes and isolated nucleic acids, probes, expression cassettes, polypeptides, antibodies, immunogenic compositions, antisense nucleic acids, amplification mixtures, and invasion-deficient strains. It also covers methods for detecting the bacterium and its nucleic acids, as well as methods for inhibiting bacterial invasion of mammalian cells.

Career Highlights

The patent lists the United States of America, as represented by the Secretary of the Department of Health and Human Services, as the assignee. Its subject matter reflects an applied research focus on understanding and addressing bacterial invasion.

Collaborations

Ribot’s named coworkers include Nigel Raymond and Frederick Quinn. Their association with the patent reflects collaborative work in the research area.

Conclusion

Efrain M. Ribot’s patent contribution centers on molecular research into *Neisseria meningitidis* serogroup B and methods relevant to detecting and inhibiting its invasion of mammalian cells.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…